Qai is operational within Catalent’s operations as Catalent continues to enhance their advanced technology application capabilities. Qai also becomes the first enterprise AI tool to be used by Catalent.
Catalent built the platform, collaborating with Microsoft. This is due to the use of Microsoft AI technologies, driven by Microsoft Azure. Additionally, Microsoft Foundry and Microsoft Fabric are utilized for data and analytics functions. The platform will help improve processes related to quality management systems. These include deviation and complaints management, hence improving analysis capabilities.
Through the AI platform, Catalent is able to find root cause analysis faster. Additionally, they will create action plans for improvements. The improved quality of reporting and minimized documentation is expected.
AI-Based Insights Help in Achieving Quality and Compliance Objectives
Qai enables users to leverage AI-driven insights within existing quality processes. Hence, teams become capable of making better and faster decisions. In addition, the platform facilitates compliance without increasing complexity.
“The launch of Qai represents an important milestone in how Catalent is applying advanced technologies, including AI, across our operations to improve consistency, accelerate insight and enable better decision-making,” said Charlie Lickfold, Chief Technology Officer, Catalent. “Innovative AI solutions like Qai strengthen the quality of our operations and better support the teams delivering critical therapies to patients around the world.”
“Qai reflects what we see as an important application of AI in life sciences: enhancing already robust data analytics and governance to deliver meaningful patient impact,” said Todd Mersch, General Manager, U.S. Life Sciences and MedTech, Microsoft. “By strengthening oversight and consistency across manufacturing processes, Qai supports Catalent’s commitment to delivering for customers and the patients they serve, helping to transform lives.”
The development of the tool has been done to bring about tangible improvements to operations. Moreover, the company seeks to empower its staff by embracing AI responsibly. Human judgment is still critical in governance. Catalent invests in innovation in order to fulfill new requirements of the pharmaceutical and biotechnology sectors. Hence, the company strives for better results for patients globally.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
